Top compounds associated with response to PRTN3


Feature Type Standardized
Nominal ANOVA
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.35 3e-28
mRNA linifanib GDSC1000 pan-cancer AAC 0.34 9e-23
mRNA AC220 GDSC1000 pan-cancer AAC 0.33 5e-22
mRNA Sorafenib CCLE pan-cancer AAC 0.36 2e-15
mRNA quizartinib CTRPv2 pan-cancer AAC 0.28 6e-15
mRNA OSI-930 GDSC1000 pan-cancer AAC 0.24 6e-13
mRNA FR-180204 GDSC1000 pan-cancer AAC 0.22 6e-11
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.22 1e-09
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.2 2e-09
mRNA TKI258 CCLE pan-cancer AAC 0.27 2e-09
Download CSV